Številke

Bibliografija osebe. Seznam zajema vsa gradiva in ne le tista, kje je oseba mentor.

Doktorska dela (1)

  1. Nina Trošt: Vpliv rekombinantnega humanega eritropoetina na rast in preživetje celic raka dojke ter njihovo odzivnost na cisplatin in tamoksifen

Diplomska dela (1)

  1. Maja Peterle: Določanje eritropoetina z izoelektričnim fokusiranjem pri alpinistih, izpostavljenih različnim nadmorskim višinam

Druga dela (13)

  1. Aleša Kristan, Nataša Debeljak, Tanja Kunej: Integration and visualization of regulatory elements and variations of the EPAS1 gene in human
  2. Zuzana Tóthová, Jana Tomc, Nataša Debeljak, Peter Solár: STAT5 as a key protein of erythropoietin signalization
  3. Jana Tomc, Nataša Debeljak: Molecular pathways involved in the development of congenital erythrocytosis
  4. Tanja Belčič, Bor Vratanar, Tadej Pajič, Saša Anžej Doma, Nataša Debeljak, Irena Preložnik Zupan, Matjaž Sever, Samo Zver: Is it possible to predict clonal thrombocytosis in triple-negative patients with isolated thrombocytosis based only on clinical or blood findings?
  5. Patrícia Kimáková, Peter Solár, Zuzana Solárová, Radovan Komel, Nataša Debeljak: Erythropoietin and its angiogenic activity
  6. Jana Tomc, Nataša Debeljak: Molecular insights into the oxygen-sensing pathway and erythropoietin expression regulation in erythropoiesis
  7. Zuzana Tóthová, Martina Šemeláková, Zuzana Solárová, Jana Tomc, Nataša Debeljak, Peter Solár: The role of PI3K/AKT and MAPK signaling pathways in erythropoietin signalization
  8. Luka Dobovišek, Fran Krstanović, Simona Borštnar, Nataša Debeljak: Cannabinoids and hormone receptor-positive breast cancer treatment
  9. Saša Anžej Doma, Nika Kraljić, Aleša Kristan, Nataša Debeljak, Aleš Maver, Tadej Pajič, Irena Preložnik Zupan: Utility of next-generation sequencing in identifying congenital erythrocytosis in patients with idiopathic erythrocytosis
  10. Luka Dobovišek, Metka Novak, Fran Krstanović, Simona Borštnar, Tamara Lah Turnšek, Nataša Debeljak: Effect of combining CBD with standard breast cancer therapeutics
  11. Eva Drnovšek, Saša Anžej Doma, Aleša Kristan, Nataša Debeljak, Irena Preložnik Zupan: Obravnava bolnikov z neklonsko eritrocitozo
  12. Tajda Tavčar Kunstič, Nataša Debeljak, Klementina Fon Tacer: Heterogeneity in hormone-dependent breast cancer and therapy
  13. Luka Dobovišek, Simona Borštnar, Nataša Debeljak, Simona Kranjc Brezar: Cannabinoids and triple-negative breast cancer treatment